Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors

Sexually Transmitted Diseases

Volumn 23, Issue 4, 1996, Pages 333-341

  Burk, Robert D ^a   Kelly, Patricia ^b   Feldman, Joseph ^b   Bromberg, Judith ^c   Vermund, Sten H ^d   Dehovitz, Jack A ^b   Landesman, Sheldon H ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONDYLOMA; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; RISK FACTOR; SEXUAL BEHAVIOR; WART VIRUS;

EID: 0029939470     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199607000-00013     Document Type: Article

References (46)

1. CDC. Condyloma acuminatum - United States, 1966-1981. MMWR 1983; 32:306-308.
2. Kiviat NB, Koutsky LA, Paavonen JA, et al. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis. 1989; 159:293-302.
3. Oriel D. Genital human papillomavirus infection. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1990; 433-441.
4. Bauer HM, YiTing MS, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265:472-477.
5. Rosenfeld WD, Rose E, Vermund SH, Schreiber K, Burk RD. Follow-up evaluation of human papillomavirus infection in adolescents. J Pediatr 1992; 121:307-311.
6. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993; 20:279-285.
7. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center. Sex Transm Dis 1993; 20:286-289.
8. Baken LA, Koutsky LA, Kuypers J, et al. Genital human papillomavirus infection among male and female sex partners: Prevalence and type-specific concordance. J Infect Dis 1995; 171:429-432.
9. Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD. Prevalence of human papillomavirus in Jamaica: Association of younger age and increased sexual activity. Sex Transm Dis 1995; 22:114-118.
10. Reeves WC, Brinton LA, Garcia M, et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989; 320:1437-1441.
11. Munoz N, Bosch FX, De Sanjose S, et al. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52:743-749.
12. Munoz N, Bosch FX, de Sanjose S, Shah KV. The role of HPV in the etiology of cervical cancer. Mutat Res 1994; 305:293-301.
13. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83:997-1003.
14. Bosch FX, Munoz N, De Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52:750-758.
15. Munoz N, Bosch FX, Shah KV, Meheus A, ed. The epidemiology of human papillomavirus and cervical cancer. IARC Scientific Publication, Vol. 119. Lyons: International Agency for Research on Cancer, 1992.
16. de Villiers E-M, Wagner D, Schneider A, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 1987; 2:703-705.
17. Ritter DB, Kadish AS, Vermund SH, Romney SL, Villari D, Burk RD. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. Am J Obstet Gynecol 1988; 159:1517-1525.
18. Morrison EAB, Ho GYF, Vermund SH, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 1991; 49:6-13.
19. Becker TM, Wheeler CM, McGough NS, Jordan SW, Dorin M, Miller J. Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic White women in New Mexico. Am J Public Health 1991; 81:582-586.
20. Melkert PW, Hopman E, van den Brule AJ, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53:919-23.
21. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20:274-278.
22. Davidson M, Schnitzer PG, Bulkow LR, et al. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women. J Infect Dis 1994; 169:792-800.
23. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-240.
24. Vermund SH, Schiffman MH, Goldberg GL, Ritter DB, Weltman A, Burk RD. Molecular diagnosis of genital human papillomavirus infection: Comparison of two methods used to collect exfoliated cervical cells. Am J Obstet Gynecol 1989; 160:304-308.
25. Goldberg GL, Vermund SH, Schiffman MH, Ritter DB, Spitzer C, Burk RD. Comparison of cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus. Am J Obstet Gynecol 1989; 161:1669-1672.
26. DeHovitz JA, Kelly P, Feldman J, et al. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol 1994; 140:1125-1134.
27. Augenbraun MH, DeHovitz JA, Feldman J, Clarke L, Landesman S, Minkoff HM. Biological false-positive syphilis test results for women infected with human immunodeficiency virus. Clin Infect Dis 1994; 19:1040-1044.
28. Burk RD, Kadish AS, Calderin S, Romney SL. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 1986; 15:982-989.
29. Workshop NCI. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1988; 262:931-934.
30. Klein RS, Ho GYF, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994; 170:1404-1409.
31. de Villiers E-M. Minireview: Heterogeneity of the human papillomavirus group. J Virol 1989; 63:4898-4903.
32. Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 1987; 79:671-677.
33. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J AIDS 1990; 3:896-903.
34. Brandsma J, Burk RD, Lancaster WD, Pfister H, Schiffman MH. Interlaboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer 1989; 43:260-262.
35. Mehta C, Patel N. StatXact: Statistical software for exact non-parametric inference. Version 2, chapter 5. Cambridge, MA: Cytel Software, 1991.
36. Van Ranst MA, Tachezy R, Delius H, Burk RD. Taxonomy of the human papillomaviruses. Papillomavirus Rep 1993; 3:61-65.
37. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170:1077-85.
38. Moscicki A-B, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. Pediatr Res 1990; 28:507-513.
39. Fisher M, Rosenfeld WD, Burk RD. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr 1991; 119:821-825.
40. Bosch FX, Munoz N, de Sanjose S, et al. Importance of human papillomavirus endemicity in the incidence of cervical cancer: An extension of the hypothesis on sexual behavior. Cancer Epidemiol Biomarkers Prev 1994; 3:375-379.
41. Reeves WC, Gary HE Jr, Johnson PR, et al. Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer. J Infect Dis 1994; 170:753-758.
42. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86:494-499.
43. Kadish AS, Romney SL, Ledwidge R, et al. Cell-mediated immune responses to HPV 16 E7 peptides are dependent on HPV type infecting the cervix: Discordance between cell-mediated and ELISA reactivity. J Gen Virol 1994; 75:2277-2284.
44. Kadish AS. Recombinant virus-like particles retain conformational epitopes of native human papillomaviruses and may be useful for vaccine development. Gynecol Oncol 1994; 55:10-12.
45. Galloway DA. Papillomavirus capsids: A new approach to identify serological markers of HPV infection. J Natl Cancer Inst 1994; 86:474-475. Editorial comment.
46. Rose RC, Reichman RC, Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol 1994; 75(pt 8):2075-2079.